Registration of patients with head and neck cancer
Prospective Registration of Head and Neck Cancer Patients for Clinical Data and Tissue Collection
This study is collecting information from patients with head and neck cancer to better understand their experiences and treatment outcomes, especially in Asian populations.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Samsung Medical Center Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Seoul) |
| Trial ID | NCT02546895 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect and analyze clinical data from patients diagnosed with head and neck cancer at Samsung Medical Center. It will involve reviewing medical records to evaluate clinical characteristics, treatment-related adverse events, and overall survival. Additionally, patients will complete questionnaires at various stages of their treatment to gather insights on their experiences and outcomes. The study seeks to address the gap in understanding the disease characteristics and treatment outcomes in Asian populations compared to Western countries.
Who should consider this trial
Good fit: Ideal candidates are adults over 19 years old diagnosed with head and neck cancer, including various histopathological types.
Not a fit: Patients with head and neck cancers who are not receiving scheduled treatment or are unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of head and neck cancer in Asian populations, leading to improved treatment strategies and patient outcomes.
How similar studies have performed: While there have been numerous studies on head and neck cancer in Western populations, this study's focus on Asian patients represents a novel approach that has not been extensively explored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults over 19 years-old * Patients diagnosed as head and neck cancer histopathologically according to American Joint Committee on Cancer, Cancer staging manual, 7th edition at Samsung Medical Center: * Comprise a part of head and neck * Oral cavity * Pharynx * Larynx * Hypopharynx * Nasal cavity * Paranasal sinus * Nasopharynx * Salivary gland * Skin in the head and neck * In case patients are diagnosed at other hospitals, it can be possible to register the tissue of cancer cell with Samsung medical center and confirm the diagnosis by pathologists of Samsung medical center. * Histopathological type: * Squamous cell carcinoma * Malignant melanoma * Sarcoma and other carcinomas are included. * Metastasis of Unknown Origin (MUO) at head and neck is included. * Patients who receive a proper treatment as scheduled. * Informed consents: patients who understand the purpose of study and are capable of giving a written consent. Exclusion criteria: * Patients who do not meet the requirements of inclusion criteria
Where this trial is running
Seoul
- Samsung Medical Center — Seoul, Korea, Republic of (Recruiting)
Study contacts
- Principal investigator: Han-Sin Jeong, M.D.Ph.D. — Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center
- Study coordinator: Han-Sin Jeong, M.D. Ph.D.
- Email: hansin.jeong@samsung.com
- Phone: 82-2-3410-0291
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.